Cargando…

Association between ceramides and coronary artery stenosis in patients with coronary artery disease

BACKGROUND: Coronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma cer...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Chenchen, Xie, Lan, Wang, Zhenjie, Zhang, Lili, Wu, Hongmei, Ni, Wei, Li, Caixia, Li, Lin, Zeng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315545/
https://www.ncbi.nlm.nih.gov/pubmed/32586390
http://dx.doi.org/10.1186/s12944-020-01329-0
_version_ 1783550277580750848
author Tu, Chenchen
Xie, Lan
Wang, Zhenjie
Zhang, Lili
Wu, Hongmei
Ni, Wei
Li, Caixia
Li, Lin
Zeng, Yong
author_facet Tu, Chenchen
Xie, Lan
Wang, Zhenjie
Zhang, Lili
Wu, Hongmei
Ni, Wei
Li, Caixia
Li, Lin
Zeng, Yong
author_sort Tu, Chenchen
collection PubMed
description BACKGROUND: Coronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma ceramide levels and the severity of stenosis, together with the onset of diseases. This aim of the present study was to investigate the association betweencertain ceramide species, coronary artery stenosis and acute coronary syndrome. METHODS: Five hundred fifty-three patients with definite or suspected CAD were recruited and received angiography. Subjects were assigned into 4 groups according to the severity of coronary artery stenosis. The measurements of 4 plasma ceramide species, namely, Cer (d18:1/16:0), Cer (d18:1/18:0), Cer (d18:1/24:1), Cer (d18:1/24:0) were carried out by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the ratio of Cer (d18:1/16:0), Cer (d18:1/18:0) and Cer (d18:1/24:1) to Cer (18:1/24:0), respectively, were calculated as index to evaluate the association between plasma ceramides levels and coronary artery stenosis. Multiple logistic regression analysis was used to establish the prognostic model for the prediction of ACS risk. RESULTS: After the adjustment by multiple clinical risk factors including age, gender, pre-existing myocardial/cerebral infarction, hemoglobin A1c% (HbA1c%), smoking and the diagnosis during index hospitalization, multiple logistic regression analysis showed that the high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c%, unstable angina (UAP) and acute myocardial infarction (AMI) diagnosis (compared with atherosclerosis) during index hospitalization were associated with more severe coronary artery stenosis. Furthermore, the prognostic model was established after adjustment of risk factors and the area under curve (AUC) of receiver operating characteristics (ROC) for the prognostic model was 0.732 and 95% CI was 0.642–0.822. CONCLUSION: The severity of coronary artery stenosis is associated with high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c% and AMI. Although the reported prognostic model showed a good discrimination, further investigation on long term MACE is needed to evaluate the role of ceramide for the prediction of MACE risk.
format Online
Article
Text
id pubmed-7315545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73155452020-06-25 Association between ceramides and coronary artery stenosis in patients with coronary artery disease Tu, Chenchen Xie, Lan Wang, Zhenjie Zhang, Lili Wu, Hongmei Ni, Wei Li, Caixia Li, Lin Zeng, Yong Lipids Health Dis Research BACKGROUND: Coronary artery stenosis induces heart diseases including acute coronary syndrome (ACS). Some studies reported the ceramide species are associated with the ACS and major adverse cardia and cerebrovascular events (MACE). However, few studies investigated the association between plasma ceramide levels and the severity of stenosis, together with the onset of diseases. This aim of the present study was to investigate the association betweencertain ceramide species, coronary artery stenosis and acute coronary syndrome. METHODS: Five hundred fifty-three patients with definite or suspected CAD were recruited and received angiography. Subjects were assigned into 4 groups according to the severity of coronary artery stenosis. The measurements of 4 plasma ceramide species, namely, Cer (d18:1/16:0), Cer (d18:1/18:0), Cer (d18:1/24:1), Cer (d18:1/24:0) were carried out by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the ratio of Cer (d18:1/16:0), Cer (d18:1/18:0) and Cer (d18:1/24:1) to Cer (18:1/24:0), respectively, were calculated as index to evaluate the association between plasma ceramides levels and coronary artery stenosis. Multiple logistic regression analysis was used to establish the prognostic model for the prediction of ACS risk. RESULTS: After the adjustment by multiple clinical risk factors including age, gender, pre-existing myocardial/cerebral infarction, hemoglobin A1c% (HbA1c%), smoking and the diagnosis during index hospitalization, multiple logistic regression analysis showed that the high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c%, unstable angina (UAP) and acute myocardial infarction (AMI) diagnosis (compared with atherosclerosis) during index hospitalization were associated with more severe coronary artery stenosis. Furthermore, the prognostic model was established after adjustment of risk factors and the area under curve (AUC) of receiver operating characteristics (ROC) for the prognostic model was 0.732 and 95% CI was 0.642–0.822. CONCLUSION: The severity of coronary artery stenosis is associated with high ratio of Cer (d18:1/24:1) to Cer (d18:1/24:0), female gender, HbA1c% and AMI. Although the reported prognostic model showed a good discrimination, further investigation on long term MACE is needed to evaluate the role of ceramide for the prediction of MACE risk. BioMed Central 2020-06-25 /pmc/articles/PMC7315545/ /pubmed/32586390 http://dx.doi.org/10.1186/s12944-020-01329-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tu, Chenchen
Xie, Lan
Wang, Zhenjie
Zhang, Lili
Wu, Hongmei
Ni, Wei
Li, Caixia
Li, Lin
Zeng, Yong
Association between ceramides and coronary artery stenosis in patients with coronary artery disease
title Association between ceramides and coronary artery stenosis in patients with coronary artery disease
title_full Association between ceramides and coronary artery stenosis in patients with coronary artery disease
title_fullStr Association between ceramides and coronary artery stenosis in patients with coronary artery disease
title_full_unstemmed Association between ceramides and coronary artery stenosis in patients with coronary artery disease
title_short Association between ceramides and coronary artery stenosis in patients with coronary artery disease
title_sort association between ceramides and coronary artery stenosis in patients with coronary artery disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315545/
https://www.ncbi.nlm.nih.gov/pubmed/32586390
http://dx.doi.org/10.1186/s12944-020-01329-0
work_keys_str_mv AT tuchenchen associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT xielan associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT wangzhenjie associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT zhanglili associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT wuhongmei associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT niwei associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT licaixia associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT lilin associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease
AT zengyong associationbetweenceramidesandcoronaryarterystenosisinpatientswithcoronaryarterydisease